Abstract

Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic vasculitis, most frequently presenting as microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA). Kidney involvement is a common and severe complication of ANCA AAV which is observed in a considerable subset of patients, mainly affecting glomeruli. However, tubulointerstitial lesions have also been described in ANCA glomerulonephritis (GN). Therefore, we aim to describe active and chronic tubulointerstitial lesions in ANCA GN subtypes by systematic scoring analogous to the Banff scoring system while also utilizing clinical and laboratory findings. Methods: A total of 49 kidney biopsies with ANCA GN were retrospectively included in a single-center cohort study between 2015–2020. Results: We report that MPO-ANCA GN is associated with more severe deterioration of kidney function independent of systemic markers of AAV disease activity, and is also associated with increased proteinuria in MPO-ANCA GN and a decreased fraction of normal glomeruli. Finally, MPO-ANCA GN showed distinct, active, and chronic tubulointerstitial lesions. Conclusion: New insights into the pathophysiology of both entities, as well as differences in the clinical presentation of MPO- versus PR3-ANCA GN, could potentially pave the way for more precise treatment regimens. Therefore, it is important to understand the differences in histopathological presentation, especially in yet underestimated active tubulointerstitial lesions of ANCA GN subtypes. This research could further improve our understanding of distinct pathophysiological mechanisms.

Highlights

  • Introduction iationsThe presence of antineutrophil cytoplasmic antibodies (ANCAs) was described more than 50 years ago [1]

  • ANCAs were found in other forms of small vessel vasculitis, microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA) [5,6]

  • We report that MPO-ANCA GN correlates with more severe deterioration of kidney function independent of systemic markers of associated vasculitis (AAV) disease activity

Read more

Summary

Introduction

The presence of antineutrophil cytoplasmic antibodies (ANCAs) was described more than 50 years ago [1]. ANCAs were discovered in the context of associated vasculitis (AAV), a small vessel vasculitis affecting multiple organ systems, including the kidneys. The discovery of ANCAs in granulomatosis with polyangiitis (GPA) marked a breakthrough in diagnostics, since GPA had long been known without a serologic marker [3,4]. ANCAs were found in other forms of small vessel vasculitis, microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA) [5,6]. Three patterns of ANCAs can be detected by immunofluorescence techniques: cytoplasmic (c-ANCA), perinuclear (p-ANCA), and atypical ( called x-ANCA) [7]. While c-ANCA or p-ANCA are detected by immunofluorescence, a separate test is needed to detect

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call